BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22321988)

  • 1. Using genetically engineered mouse models to validate candidate cancer genes and test new therapeutic approaches.
    van Miltenburg MH; Jonkers J
    Curr Opin Genet Dev; 2012 Feb; 22(1):21-7. PubMed ID: 22321988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered mouse models in oncology research and cancer medicine.
    Kersten K; de Visser KE; van Miltenburg MH; Jonkers J
    EMBO Mol Med; 2017 Feb; 9(2):137-153. PubMed ID: 28028012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying drug resistance using genetically engineered mouse models for breast cancer.
    Rottenberg S; Pajic M; Jonkers J
    Methods Mol Biol; 2010; 596():33-45. PubMed ID: 19949919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models of cancer.
    Cheon DJ; Orsulic S
    Annu Rev Pathol; 2011; 6():95-119. PubMed ID: 20936938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).
    Telang N; Katdare M
    Oncol Rep; 2011 May; 25(5):1195-201. PubMed ID: 21399881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling therapy resistance in genetically engineered mouse cancer models.
    Rottenberg S; Jonkers J
    Drug Resist Updat; 2008; 11(1-2):51-60. PubMed ID: 18165147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development.
    Roper J; Hung KE
    Trends Pharmacol Sci; 2012 Aug; 33(8):449-55. PubMed ID: 22739258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
    Singh M; Johnson L
    Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional mouse models of cancer.
    Vignjevic D; Fre S; Louvard D; Robine S
    Handb Exp Pharmacol; 2007; (178):263-87. PubMed ID: 17203659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.
    Kasper S
    J Cell Biochem; 2005 Feb; 94(2):279-97. PubMed ID: 15565647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models for human head and neck squamous cell carcinomas.
    Lu SL; Herrington H; Wang XJ
    Head Neck; 2006 Oct; 28(10):945-54. PubMed ID: 16721744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically engineered models have advantages over xenografts for preclinical studies.
    Becher OJ; Holland EC
    Cancer Res; 2006 Apr; 66(7):3355-8, discussion 3358-9. PubMed ID: 16585152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of genetically engineered mouse models of colorectal carcinoma to enable translational biology and drug development.
    Roper J; Martin ES; Hung KE
    Curr Protoc Pharmacol; 2014 Jun; 65():14.29.1-10. PubMed ID: 24934606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically modified mouse models for biomarker discovery and preclinical drug testing.
    Kucherlapati R
    Clin Cancer Res; 2012 Feb; 18(3):625-30. PubMed ID: 22298895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
    Klein RD
    Mutat Res; 2005 Aug; 576(1-2):111-9. PubMed ID: 15885713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular biology of pulmonary metastasis.
    Krishnan K; Khanna C; Helman LJ
    Thorac Surg Clin; 2006 May; 16(2):115-24. PubMed ID: 16805200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically modified mice and their use in developing therapeutic strategies for prostate cancer.
    Kasper S; Smith JA
    J Urol; 2004 Jul; 172(1):12-9. PubMed ID: 15201729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mouse Tumor Biology Database: integrated access to mouse cancer biology data.
    Krupke D; Näf D; Vincent M; Allio T; Mikaelian I; Sundberg J; Bult C; Eppig J
    Exp Lung Res; 2005 Mar; 31(2):259-70. PubMed ID: 15824024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.